메뉴 건너뛰기




Volumn 26, Issue 1, 2008, Pages 113-116

Glucocorticoid treatment in rheumatoid arthritis: Low-dose therapy does not reduce responsiveness to higher doses

Author keywords

Disease activity score; Glucocorticoids; Rheumatoid arthritis

Indexed keywords

CALCIUM; CELECOXIB; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; TRAMADOL; VITAMIN D;

EID: 40749131730     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (30)
  • 1
    • 0142124934 scopus 로고    scopus 로고
    • Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis
    • PINCUS T, YAZICI Y, SOKKA T, ALETAHA D, SMOLEN JS: Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 2003; 21 (Suppl 31): S179-S185.
    • (2003) Clin Exp Rheumatol , vol.21 , Issue.SUPPL. 31
    • PINCUS, T.1    YAZICI, Y.2    SOKKA, T.3    ALETAHA, D.4    SMOLEN, J.S.5
  • 2
    • 0036021133 scopus 로고    scopus 로고
    • Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study
    • ALETAHA D, SMOLEN JS: Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. J Rheumatol 2002; 29: 1631-8.
    • (2002) J Rheumatol , vol.29 , pp. 1631-1638
    • ALETAHA, D.1    SMOLEN, J.S.2
  • 3
    • 0142218522 scopus 로고    scopus 로고
    • RheumatoidWarthritis in 2003: Where are we now with treatment? Ann Rheum Dis
    • Suppl. 2
    • WEINBLATT ME: RheumatoidWarthritis in 2003: where are we now with treatment? Ann Rheum Dis 2003; 62 (Suppl. 2): Ii94-ii96.
    • (2003)
    • WEINBLATT, M.E.1
  • 4
    • 0142061680 scopus 로고    scopus 로고
    • DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease
    • ALETAHA D, SMOLEN JS: DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease. Clin Exp Rheumatol 2003; 21 (Suppl. 31): S169-S173.
    • (2003) Clin Exp Rheumatol , vol.21 , Issue.SUPPL. 31
    • ALETAHA, D.1    SMOLEN, J.S.2
  • 5
    • 3242677099 scopus 로고    scopus 로고
    • Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial
    • GRIGOR C, CAPELL H, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004; 364: 263-9.
    • (2004) Lancet , vol.364 , pp. 263-269
    • GRIGOR, C.1    CAPELL, H.2    STIRLING, A.3
  • 6
    • 15844389496 scopus 로고    scopus 로고
    • Practices for managing a flare of long-standing rheumatoid arthritis: Survey among French rheumatologists
    • MARAVIC M, BERGE C, DAURES JP, BOISSIER MC: Practices for managing a flare of long-standing rheumatoid arthritis: Survey among French rheumatologists. Clin Exp Rheumatol 2005; 23: 36-42.
    • (2005) Clin Exp Rheumatol , vol.23 , pp. 36-42
    • MARAVIC, M.1    BERGE, C.2    DAURES, J.P.3    BOISSIER, M.C.4
  • 7
    • 0030751946 scopus 로고    scopus 로고
    • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    • BOERS M, VERHOEVEN AC, MARKUSSE HM et al.: Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18.
    • (1997) Lancet , vol.350 , pp. 309-318
    • BOERS, M.1    VERHOEVEN, A.C.2    MARKUSSE, H.M.3
  • 8
    • 4644360558 scopus 로고    scopus 로고
    • Attitudes to early rheumatoid arthritis: Changing patterns. Results of a survey
    • ALETAHA D, EBERL G, NELL VP, MACHOLD KP, SMOLEN JS: Attitudes to early rheumatoid arthritis: Changing patterns. Results of a survey. Ann Rheum Dis 2004; 63: 1269-75.
    • (2004) Ann Rheum Dis , vol.63 , pp. 1269-1275
    • ALETAHA, D.1    EBERL, G.2    NELL, V.P.3    MACHOLD, K.P.4    SMOLEN, J.S.5
  • 9
    • 0028997898 scopus 로고    scopus 로고
    • VAN GESTEL AM, LAAN RF, HAAGSMA CJ, VAN DE PUTTE LB, VAN RIEL PL: Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial. Br J Rheumatol 1995; 34: 347-51.
    • VAN GESTEL AM, LAAN RF, HAAGSMA CJ, VAN DE PUTTE LB, VAN RIEL PL: Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial. Br J Rheumatol 1995; 34: 347-51.
  • 10
    • 0031862891 scopus 로고    scopus 로고
    • Anti-inflammatory actions of Mlucocorticoids: Molecular mechanisms
    • BARNES PJ: Anti-inflammatory actions of Mlucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557-72.
    • (1998) Clin Sci (Lond) , vol.94 , pp. 557-572
    • BARNES, P.J.1
  • 11
    • 0142124932 scopus 로고    scopus 로고
    • Low dose glucocorticoids in early rheumatoid arthritis
    • STRAND V, SIMON LS: Low dose glucocorticoids in early rheumatoid arthritis. Clin Exp Rheumatol 2003; 21 (Suppl. 31): S186-S190.
    • (2003) Clin Exp Rheumatol , vol.21 , Issue.SUPPL. 31
    • STRAND, V.1    SIMON, L.S.2
  • 12
    • 0029053188 scopus 로고
    • The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
    • KIRWAN JR: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995; 333: 142-6.
    • (1995) N Engl J Med , vol.333 , pp. 142-146
    • KIRWAN, J.R.1
  • 13
    • 27744466694 scopus 로고    scopus 로고
    • Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial
    • SVENSSON B, BOONEN A, ALBERTSSON K, VAN DER HD, KELLER C, HAFSTROM I: Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial. Arthritis Rheum 2005; 52: 3360-70.
    • (2005) Arthritis Rheum , vol.52 , pp. 3360-3370
    • SVENSSON, B.1    BOONEN, A.2    ALBERTSSON, K.3    VAN DER, H.D.4    KELLER, C.5    HAFSTROM, I.6
  • 14
    • 0036140321 scopus 로고    scopus 로고
    • VAN EVERDINGEN AA, JACOBS JW, SIEWERTSZ VAN REESEMA DR, BIJLSMA JW: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12.
    • VAN EVERDINGEN AA, JACOBS JW, SIEWERTSZ VAN REESEMA DR, BIJLSMA JW: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12.
  • 15
    • 27744525171 scopus 로고    scopus 로고
    • Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double-blind, placebo-controlled trial
    • WASSENBERG S, RAU R, STEINFELD P, ZEIDLER H: Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 3371-80.
    • (2005) Arthritis Rheum , vol.52 , pp. 3371-3380
    • WASSENBERG, S.1    RAU, R.2    STEINFELD, P.3    ZEIDLER, H.4
  • 16
    • 0032693752 scopus 로고    scopus 로고
    • Combination DMARD therapy including corticosteroids in early rheumatoid arthritis
    • MOTTONEN TT, HANNONEN PS, BOERS M: Combination DMARD therapy including corticosteroids in early rheumatoid arthritis. Clin Exp Rheumatol 1999; 17 (Suppl. 18): S59-S65.
    • (1999) Clin Exp Rheumatol , vol.17 , Issue.SUPPL. 18
    • MOTTONEN, T.T.1    HANNONEN, P.S.2    BOERS, M.3
  • 17
    • 0036166382 scopus 로고    scopus 로고
    • COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
    • LANDEWE RB, BOERS M, VERHOEVEN AC et al.: COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 347-56.
    • (2002) Arthritis Rheum , vol.46 , pp. 347-356
    • LANDEWE, R.B.1    BOERS, M.2    VERHOEVEN, A.C.3
  • 18
    • 0034021412 scopus 로고    scopus 로고
    • Glucocorticoid dose dependent down-regulation of glucocorticoid receptors in patients with rheumatic diseases
    • SANDEN S, TRIPMACHER R, WELTRICH R et al.: Glucocorticoid dose dependent down-regulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000; 27: 1265-70.
    • (2000) J Rheumatol , vol.27 , pp. 1265-1270
    • SANDEN, S.1    TRIPMACHER, R.2    WELTRICH, R.3
  • 19
    • 0036304271 scopus 로고    scopus 로고
    • Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis
    • NEECK G, KLUTER A, DOTZLAW H, EGGERT M: Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann N Y Acad Sci 2002; 966: 491-5.
    • (2002) Ann N Y Acad Sci , vol.966 , pp. 491-495
    • NEECK, G.1    KLUTER, A.2    DOTZLAW, H.3    EGGERT, M.4
  • 20
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • ARNETT, F.C.1    EDWORTHY, S.M.2    BLOCH, D.A.3
  • 21
    • 40749123841 scopus 로고    scopus 로고
    • WOLF J, KAPRAL T, GRISAR J et al.: Long-Term Low-Dose Glucocorticoid Therapy Does not Significantly Reduce Responsiveness to Higher Steroid Doses. 52, Number 9[Abstract Supplement 2005 Annual Scientific Meeting], S567, Abstract 1508. 16-11-2005. Arthritis Rheum.
    • WOLF J, KAPRAL T, GRISAR J et al.: Long-Term Low-Dose Glucocorticoid Therapy Does not Significantly Reduce Responsiveness to Higher Steroid Doses. Volume 52, Number 9[Abstract Supplement 2005 Annual Scientific Meeting], S567, Abstract 1508. 16-11-2005. Arthritis Rheum.
  • 22
    • 34848883035 scopus 로고    scopus 로고
    • Endothelial progenitor cells in active rheumatoid arthritis: Effects of tumour necrosis factor and glucocorticoid therapy
    • GRISAR JC, ALETAHA D, STEINER CW et al.: Endothelial progenitor cells in active rheumatoid arthritis: Effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis 2007; 66: 1284-8.
    • (2007) Ann Rheum Dis , vol.66 , pp. 1284-1288
    • GRISAR, J.C.1    ALETAHA, D.2    STEINER, C.W.3
  • 23
    • 0028815803 scopus 로고
    • HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
    • PREVOO ML, 'HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
    • (1995) Arthritis Rheum , vol.38 , pp. 44-48
    • PREVOO, M.L.1
  • 24
    • 27744514865 scopus 로고    scopus 로고
    • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
    • GOEKOOP-RUITERMAN YP, VRIES-BOUWSTRA JK, ALLAART CF et al.: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-90.
    • (2005) Arthritis Rheum , vol.52 , pp. 3381-3390
    • GOEKOOP-RUITERMAN, Y.P.1    VRIES-BOUWSTRA, J.K.2    ALLAART, C.F.3
  • 25
    • 0344127554 scopus 로고    scopus 로고
    • A simplified disease activity index for rheumatoid arthritis for use in clinical practice
    • SMOLEN JS, BREEDVELD FC, SCHIFF MH et al.: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244-57.
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 244-257
    • SMOLEN, J.S.1    BREEDVELD, F.C.2    SCHIFF, M.H.3
  • 26
    • 33644804877 scopus 로고    scopus 로고
    • The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis
    • ALETAHA D, SMOLEN J: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S100-S108.
    • (2005) Clin Exp Rheumatol , vol.23 , Issue.SUPPL. 39
    • ALETAHA, D.1    SMOLEN, J.2
  • 27
    • 0024521396 scopus 로고
    • Visual analogue scales as a measure of pain in arthritis: A study of overall pain and pain in individual joints at rest and on movement
    • BADLEY EM, PAPAGEORGIOU AC: Visual analogue scales as a measure of pain in arthritis: A study of overall pain and pain in individual joints at rest and on movement. J Rheumatol 1989; 16: 102-5.
    • (1989) J Rheumatol , vol.16 , pp. 102-105
    • BADLEY, E.M.1    PAPAGEORGIOU, A.C.2
  • 28
    • 0037643416 scopus 로고    scopus 로고
    • Molecular mechanisms of glucocorticoid action and resistance
    • SCHAAF MJ, CIDLOWSKI JA: Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83(1-5):37-48.
    • (2002) J Steroid Biochem Mol Biol , vol.83 , Issue.1-5 , pp. 37-48
    • SCHAAF, M.J.1    CIDLOWSKI, J.A.2
  • 29
    • 0028132004 scopus 로고
    • Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance
    • SCHLAGHECKE R, BEUSCHER D, KORNELY E, SPECKER C: Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 1994; 37: 1127-31.
    • (1994) Arthritis Rheum , vol.37 , pp. 1127-1131
    • SCHLAGHECKE, R.1    BEUSCHER, D.2    KORNELY, E.3    SPECKER, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.